Clinical Trials

New Search
Title   A Multicenter, Open-label, Randomized, Event-driven Study to Assess Efficacy, Safety and Pharmacokinetics of Macitentan Versus Standard of Care in Children With Pulmonary Arterial Hypertension (PAH) (TOMORROW)
Disease/Condition   Heart and Vascular Diseases,Pediatrics,Pulmonary Hypertension,Lung Diseases
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Nicole Sutton, MD
Contact Name   Chelsie Cornelius
Contact Email
IRB/Protocol Number   16-10-366-01
Status   Active/Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   Yes
Sub-Specialty   Cardiology - PAH